As of 2025-06-20, the Relative Valuation of Helix Biopharma Corp (HBP.TO) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.92 CAD, the upside of Helix Biopharma Corp based on Relative Valuation is -101.5%.
The range of the Relative Valuation is (0.01) - (0.04) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.3x | 0.1x |
| Forward P/E multiples | 0.1x - 0.3x | 0.1x |
| Fair Price | (0.01) - (0.04) | (0.01) |
| Upside | -101.2% - -104.4% | -101.5% |
| Date | P/E |
| 2025-05-28 | -6.87 |
| 2025-05-27 | -6.87 |
| 2025-05-26 | -7.10 |
| 2025-05-22 | -7.17 |
| 2025-05-20 | -7.10 |
| 2025-05-16 | -7.17 |
| 2025-05-15 | -7.25 |
| 2025-05-14 | -7.17 |
| 2025-05-13 | -7.17 |
| 2025-05-12 | -7.17 |
| 2025-05-09 | -7.17 |
| 2025-05-08 | -7.10 |
| 2025-05-06 | -7.17 |
| 2025-05-01 | -7.17 |
| 2025-04-30 | -7.17 |
| 2025-04-29 | -5.83 |
| 2025-04-28 | -5.83 |
| 2025-04-25 | -5.83 |
| 2025-04-24 | -5.83 |
| 2025-04-23 | -5.83 |
| 2025-04-22 | -5.75 |
| 2025-04-15 | -5.83 |
| 2025-04-14 | -5.83 |
| 2025-04-11 | -5.75 |
| 2025-04-03 | -5.90 |
| 2025-04-02 | -5.86 |
| 2025-04-01 | -5.98 |
| 2025-03-31 | -5.98 |
| 2025-03-26 | -5.98 |
| 2025-03-19 | -5.98 |
| 2025-03-18 | -7.10 |
| 2025-03-14 | -6.72 |
| 2025-03-13 | -6.57 |